DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. (XRAY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
xray · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for DENTSPLY SIRONA Inc. (XRAY) measures how much investors pay for each dollar of the company's trailing earnings. XRAY's current PE ratio of N/A is calculated by dividing its stock price of $10.26 by its TTM earnings per share of -$3.14.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 13 fiscal years · Front-end computedMinQ1 · 25%22.1x
MedianQ3 · 75%49.3x
Max
At N/A, XRAY's current P/E is lower than in 0% of its annual fiscal year readings over the past 13 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
DENTSPLY SIRONA Inc.You XRAY | $2.1B | N/A | — | -$3.14 |
 Agios Pharmaceuticals, Inc. AGIO | $1.6B | N/A | — | -$7.12 |
 Beam Therapeutics Inc. BEAM | $3.1B | N/A | — | -$0.81 |
 Bausch Health Companies Inc. BHC | $1.9B | 16.14x | -98.7% | $0.43 |
 Concentra Group Holdings Parent, Inc. CON | $3.3B | 14.42x | -98.8% | $1.36 |
 Haemonetics Corporation HAE | $3.4B | 26.20x | -97.8% | $2.06 |
 ICU Medical, Inc. ICUI | $3.4B | 4802.44x | +295.3% | $0.03 |
Industry Average 4 peers with valid PE | — | 1214.80x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-3.00 | — | |
2024-12-31 FY2024 | — | $-4.48 | — | |
2023-12-31 FY2023 | — | $-0.62 | — | |
2022-12-31 FY2022 | — | $-4.41 | — | |
2021-12-31 FY2021 | 29.65x | $1.88 | — | |
2020-12-31 FY2020 | — | $-0.33 | — | |
2019-12-31 FY2019 | 49.32x | $1.15 | — | |
2018-12-31 FY2018 | — | $-4.51 | — | |
2017-12-31 FY2017 | — | $-6.76 | — | |
2016-12-31 FY2016 | 29.27x | $1.97 | -13.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for DENTSPLY SIRONA Inc. (XRAY) measures how much investors pay for each dollar of the company's trailing earnings. XRAY's current PE ratio of N/A is calculated by dividing its stock price of $10.26 by its TTM earnings per share of -$3.14.
Frequently asked questions
XRAY pe ratio · 6 questionsXRAY's current PE ratio is N/A as of 2026-06-09, based on a stock price of $10.26 and TTM EPS of -$3.14. Data sourced from Financial Modeling Prep via XRAY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DENTSPLY SIRONA Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09